Biotechnological intervention has transformed the vaccination technology' – Discuss.

Question

Ghissu Editorial · Accepted Answer

Biotechnology has transformed vaccination by replacing slow whole-pathogen methods with DNA, protein sub-unit and mRNA platforms that are faster, safer and more precise. India's ZyCoV-D, CORBEVAX, GEMCOVAC-19 and the intranasal iNCOVACC show the shift, though regulatory delays and weak public-private links still limit it.

**Introduction**

Biotechnological interventions have revolutionized vaccination technology, accelerating development and enhancing vaccine efficacy, crucial for India’s public health landscape and global vaccine supply. India’s position as the “pharmacy of the world,” producing over 60% of global vaccines, highlights biotechnology’s role in improving vaccine accessibility and innovation. The COVID-19⟦1⟧ pandemic underscored the importance of rapid vaccine development, with states like ==Andhra Pradesh== playing a key role in vaccine delivery.

**Nature and Scope of Biotechnological Interventions**

2. **Clinical Trial Infrastructure**: India’s 54 clinical trial sites, including ==Andhra Pradesh==, equipped with Good Clinical Practice (GCP) compliance and electronic data capture systems, enable rapid vaccine testing and real-time safety monitoring. This network supports accelerated vaccine development and robust data collection.

3. **Bioinformatics and Genomic Surveillance**: Integration of bioinformatics with biotechnology allows genome sequencing of pathogens and hosts, aiding vaccine design tailored to genetic diversity. The Department of Biotechnology’s One Day One Genome project enhances understanding of population genetics, critical for vaccine efficacy in diverse regions like ==Andhra Pradesh==.

**Impact on Vaccine Effectiveness and Delivery**

4. **Improved Efficacy and Accessibility**: Bharat Biotech’s Covaxin, which received WHO emergency use listing after rigorous trials, and thermostable intranasal vaccines like iNCOVACC improve immunogenicity and simplify storage and administration. These advances support India’s Universal Immunisation Programme, which annually reaches 2.9 crore pregnant women and 2.54 crore newborns.

**Conclusion**

Biotechnological interventions have transformed vaccination technology by enabling rapid development, improved efficacy, and wider accessibility. However, focused policy reforms, infrastructure investment, and robust public-private collaboration are vital to sustain and expand these gains in India’s vaccine ecosystem.

‘బయోటెక్నలాజికల్ జోక్యం టీకా సాంకేతికతను మార్చివేసింది’ – చర్చించండి.

Model answer

ఈ ప్రశ్నను ప్రాక్టీస్ చేయండి

మానవ వ్యాధులు; జన్యు ఇంజనీరింగ్ ప్రాథమిక అంశాలు; వ్యవసాయంలో బయోటెక్నాలజీ; టీకాలు54 questions

Ghissu